文献速递神经肿瘤神经重症

放化疗对脑肿瘤患者脑容量的影响研究

Investigation of the effects of radiotherapy and chemotherapy on brain volume in cancer patients: brain tumor study.
PubMed 文献 · J Neurooncol · 2026-02-13

本研究回顾性分析了47例原发或转移性脑肿瘤患者,于治疗前、放疗后及化疗后三个时间点行脑MRI体积测量。结果显示放疗后端脑体积显著增大、化疗后回落至基线,间脑体积在放疗后显著且持续缩小(p < 0.05),其余脑区及肿瘤体积无显著变化(p = 0.456)。

要点

  • 放疗后端脑体积一过性增大,更可能反映治疗相关水肿或炎症而非功能改善。
  • 间脑体积在放疗后显著且持续下降(p < 0.05),或提示早期治疗相关组织脆弱性。
  • 肿瘤体积三时间点无显著差异(p = 0.456),提示治疗期间疾病稳定。

核心结论

  • 放疗和化疗导致脑区特异性的体积改变,端脑增大为一过性、间脑缩小持续存在。
  • 将自动体积评估纳入常规随访可能有助于早期发现治疗相关结构改变并支持个体化治疗规划。

研究设计与样本

  • 回顾性队列研究,纳入2012至2023年在Inonu大学Turgut Özal医学中心治疗的47例18-90岁原发或转移性脑肿瘤患者。
  • 于治疗前、放疗后、化疗后三个时间点评估脑MRI,放疗中位剂量60 Gy、30-33次分割,化疗药物为替莫唑胺。
  • 采用MRICloud测量端脑、间脑、脑室、白质、脑干、小脑及大脑皮层体积,VolBrain平台量化肿瘤体积,统计方法为重复测量ANOVA。

主要发现

  • 放疗后端脑体积出现统计学显著增大,化疗后回落至接近基线。
  • 间脑在放疗后出现显著且持续的体积缩小(p < 0.05)。
  • 脑室、白质、脑干、小脑及大脑皮层体积未见统计学显著变化(p > 0.05)。
  • 肿瘤体积在三个时间点比较无显著差异(p = 0.456),提示治疗期间疾病稳定。

关键数值与推荐

  • 放疗中位剂量60 Gy,30-33次分割。
  • 间脑体积下降p < 0.05;其余脑区体积变化p > 0.05;肿瘤体积变化p = 0.456。

临床怎么用

  • 随访中可关注放疗后间脑体积持续缩小,作为早期治疗相关组织损伤的影像学提示。
  • 端脑放疗后一过性增大应首先考虑水肿或炎症,避免误判为疗效或功能改善。
  • 可考虑将自动体积评估纳入常规影像随访以辅助个体化治疗规划。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Brain tumors, characterized by the uncontrolled proliferation of abnormal cells within cerebral tissue, remain clinically challenging entities. Radiotherapy and chemotherapy constitute fundamental therapeutic modalities; however, their effects on healthy brain structures are not fully understood. This study aimed to evaluate the impact of these treatments on volumetric changes in brain structures and tumor size in patients with primary or metastatic brain tumors. METHODS: A retrospective cohort of 47 patients aged 18-90 years treated at Inonu University Turgut Özal Medical Center between 2012 and 2023 was analyzed. Brain MRI scans were evaluated at three time points: pre-treatment, post-radiotherapy, and post-chemotherapy. Radiotherapy was delivered at a median dose of 60 Gy in 30-33 fractions, and temozolomide was used as the chemotherapy agent. Volumetric measurements of the telencephalon, diencephalon, ventricles, white matter, brainstem, cerebellum, and cerebral cortex were performed using MRICloud, while tumor volumes were quantified using the VolBrain platform. All volumetric differences were statistically tested using repeated-measures ANOVA with corresponding p-values reported. RESULTS: A statistically significant increase in telencephalon volume was observed after radiotherapy, followed by a return toward baseline measurements after chemotherapy. The diencephalon demonstrated a significant and persistent volume reduction following radiotherapy (p < 0.05). No statistically significant volumetric changes were identified in the ventricles, white matter, brainstem, cerebellum, or cerebral cortex (p > 0.05). Tumor volume changes were also statistically evaluated and showed no significant differences across the three time points (p = 0.456), indicating stable disease during the treatment course. CONCLUSION: Radiotherapy and chemotherapy lead to region-specific volumetric alterations in the brain. The transient telencephalon enlargement is more likely attributable to treatment-related edema or inflammatory processes rather than functional improvement. The persistent diencephalon volume decline may reflect early treatment-related tissue vulnerability. Incorporating automated volumetric assessment into routine follow-up may support early detection of therapy-related structural changes and facilitate more personalized treatment planning.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Deniz B, Arpaci MF, Pekmez H, et al. Investigation of the effects of radiotherapy and chemotherapy on brain volume in cancer patients: brain tumor study. J Neurooncol. 2026. PMID: 41686371. doi:10.1007/s11060-025-05366-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。